[VRTX] YoY Quarter Result on 30-Jun-2019 [#Q2]

Stock
[VRTX] Vertex Pharmaceuticals Incorporated
Announcement Date
01-Aug-2019
Financial Year
2019
Quarter
30-Jun-2019 [#Q2]
Profit Trend
QoQ- -0.45%
YoY- 28.97%
Quarter Report
VRTX's Result
VRTX's Financial Summary
View:
Show?
Quarter Result
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
Revenue 2,196,200 1,793,370 1,524,485 941,293 752,157 544,135 431,608 31.13%
PBT 1,024,400 -44,255 824,770 327,138 216,591 35,506 -18,021 -
Tax 213,900 -111,179 -12,500 59,711 10,341 4,337 18,130 50.85%
NP 810,500 66,924 837,270 267,427 207,360 17,996 -64,525 -
Tax Rate -20.88% - 1.52% -18.25% -4.77% -12.21% - -
Total Cost 1,385,700 1,726,446 687,215 673,866 544,797 526,139 496,133 18.66%
Ratio Analysis
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
NP Margin 36.90 3.73 54.92 28.41 27.57 3.31 -14.95 -
Per Share
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
EPS 3.17 0.26 3.22 1.04 0.82 0.07 -0.26 -
EPS Diluted 3.13 0.26 3.18 1.03 0.80 0.07 -0.26 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.